Bachem, CH0012530207

Bachem stock gains as shares trade near the 52-week high

Published on 09/22/2026 at 17:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bachem stock reached CHF 81.75 on September 22, 2026, only 1.83 percent below its 52-week high. EPS estimates for fiscal 2026 stand at CHF 2.40.

Fotorealistische Peptid-Produktionsanlage mit Alpenpanorama im Hintergrund
Bachem Holding AG (CH0012530207) betreibt moderne Peptid-Produktionsanlagen mit Bioreaktoren vor Schweizer Alpenpanorama, Illustration mit AI erstellt.

Bachem stock (ISIN CH0012530207) reached CHF 81.75 on the SIX Swiss Exchange at 12:28 p.m. local time on September 22, 2026, up 1.2 percent during the session. The price stood 1.83 percent below the 52-week high of CHF 83.25 recorded on May 8, 2026, while the 52-week low was CHF 48.52 on November 19, 2025.

Shares approach the yearly high

The market move places Bachem close to the upper end of its recent trading range. From the 52-week low of CHF 48.52 to CHF 81.75, the stock has gained 68.49 percent based on the quoted levels, while the remaining distance to the yearly high is CHF 1.50.

The session began at CHF 81.50, according to Finanzen.ch on September 22, 2026. That starting level and the intraday quote show a move of CHF 0.25, or 0.31 percent, from the open to the 12:28 p.m. quotation.

EPS estimate sets valuation lens

For fundamental context, fiscal 2026 earnings per share are estimated at CHF 2.40, according to Ad-hoc-News on September 21, 2026. Against the quoted share price of CHF 81.75, that estimate corresponds to an indicative price-to-earnings multiple of 34.06, making earnings delivery and capacity expansion central valuation variables.

The same September 21, 2026 report described Bachem as a specialty pharmaceutical supplier whose pipeline and production capacity remain important reference points for the market. The article also cited an intraday price of CHF 79.60, a session high of CHF 80.10 and volume of 10,328 shares on the SIX Swiss Exchange.

Market value near CHF 6.05 billion

Market data compiled by Finanz und Wirtschaft placed Bachem near CHF 80.80 and its market capitalization near CHF 6,054.80 million on September 21, 2026, according to Ad-hoc-News. The comparison between that market value and the current SIX quotation highlights how closely the stock is trading to its recent upper range.

Stock closes at CHF 81.75

Bachem stock traded at CHF 81.75 on the SIX Swiss Exchange as of 12:28 p.m. local time on September 22, 2026, up 1.2 percent during the session. The quote was CHF 1.50 below the 52-week high of CHF 83.25.

Bachem stock at a glance

  • Company: Bachem Holding AG
  • ISIN: CH0012530207
  • Ticker: BANB
  • Trading venue: SIX Swiss Exchange
  • Price as of September 22, 2026, 12:28 p.m.: CHF 81.75
  • Market capitalization: CHF 6,054.80 million as of September 21, 2026
  • Sector / Industry: Health Care / Biotechnology
  • Index membership: SPI

More news and analyses on Bachem stock

Disclaimer...

en | CH0012530207 | BACHEM | boerse | 70157169 | bgmi